Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ceapro Inc. (CRPOF : OTC)

• Company Description    Ceapro Inc. is a biotechnology company. The company develop and commercialize ingredients for human and animal health markets. Its product pipeline includes botanical product & oat product. The company's technology consists of PGX Technology. Ceapro Inc. is headquartered in Edmonton, Canada. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.45 Daily Weekly Monthly 20 Day Moving Average: 15,042 shares Shares Outstanding: 77.69 (millions) Market Capitalization: $35.00 (millions) Beta: 1.85 52 Week High: $0.59 52 Week Low: $0.33 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.54% 17.75% 12 Week 25.14% 40.64% Year To Date -6.15% 14.66%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7824 51 Avenue NW - Edmonton,A0 T6E 6W2 CAN ph: 780-421-4555 fax: 780-421-1320 czo@jtcir.com http://www.ceapro.com

• General Corporate Information    Officers Gilles Gagnon - Chief Executive Officer and President Glenn Rourke - Chairman Stacy Prefontaine - Chief Financial Officer Leoni DeJoya - Vice President Marc Morisset - Director Peer Information Ceapro Inc. (CORR.) Ceapro Inc. (RSPI) Ceapro Inc. (CGXP) Ceapro Inc. (BGEN) Ceapro Inc. (GTBP) Ceapro Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 149907107 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/25/22 Share - Related Items Shares Outstanding: 77.69 Most Recent Split Date: (:1) Beta: 1.85 Market Capitalization: $35.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/25/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 9.01 PEG Ratio: - Price Ratios Price/Book: 1.61 Price/Cash Flow: 9.29 Price / Sales: 2.35 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: 100.00% Sales Growth vs. Year Ago Period: 31.21% vs. Previous Quarter: 72.40% ROE 03/31/22 - 16.25 12/31/21 - 10.92 09/30/21 - 6.23 ROA 03/31/22 - 14.00 12/31/21 - 9.37 09/30/21 - 5.25 Current Ratio 03/31/22 - - 12/31/21 - 12.06 09/30/21 - 8.07 Quick Ratio 03/31/22 - - 12/31/21 - 10.37 09/30/21 - 7.03 Operating Margin 03/31/22 - 23.11 12/31/21 - 16.54 09/30/21 - 9.55 Net Margin 03/31/22 - 23.11 12/31/21 - 16.54 09/30/21 - 9.55 Pre-Tax Margin 03/31/22 - - 12/31/21 - 15.23 09/30/21 - 9.85 Book Value 03/31/22 - - 12/31/21 - 0.28 09/30/21 - 0.27 Inventory Turnover 03/31/22 - - 12/31/21 - 5.61 09/30/21 - 6.15 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©